{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:34:50Z","timestamp":1773160490714,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.neuro.2015.05.004","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T16:35:22Z","timestamp":1432226122000},"page":"45-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine"],"prefix":"10.1016","volume":"49","author":[{"given":"A.","family":"Ranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6141-3592","authenticated-orcid":false,"given":"J.","family":"Kalita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuro.2015.05.004_bib0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","article-title":"Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy","volume":"44","author":"Brewer","year":"1987","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.neuro.2015.05.004_bib0040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archneur.63.4.521","article-title":"Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease","volume":"63","author":"Brewer","year":"2006","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.neuro.2015.05.004_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.trsl.2009.05.002","article-title":"Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine","volume":"154","author":"Brewer","year":"2009","journal-title":"Transl Res"},{"issue":"3","key":"10.1016\/j.neuro.2015.05.004_bib0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10545-011-9422-5","article-title":"Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms","volume":"35","author":"Bruha","year":"2012","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"10.1016\/j.neuro.2015.05.004_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ng1293-327","article-title":"The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene","volume":"5","author":"Bull","year":"1993","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.neuro.2015.05.004_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1212\/WNL.35.1.73","article-title":"Validity and reliability of a rating scale for the primary torsion dystonias","volume":"35","author":"Burke","year":"1985","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neuro.2015.05.004_bib0120","doi-asserted-by":"crossref","first-page":"e37709","DOI":"10.1371\/journal.pone.0037709","article-title":"Penicillamine increases free copper and enhances oxidative stress in the brain of toxic milk mice","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuro.2015.05.004_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2008.10.056","article-title":"Copper transport to the brain by the blood\u2013brain barrier and blood\u2013CSF barrier","volume":"1248","author":"Choi","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.neuro.2015.05.004_bib0105","volume":"vol. 2","author":"Daroff","year":"2012"},{"issue":"9","key":"10.1016\/j.neuro.2015.05.004_bib0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpneuro0291","article-title":"Wilson's disease: an update","volume":"2","author":"Das","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neuro.2015.05.004_bib0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0300-483X(03)00159-8","article-title":"Copper toxicity, oxidative stress, and antioxidant nutrients","volume":"189","author":"Gaetke","year":"2003","journal-title":"Toxicology"},{"issue":"2 (Pt 1)","key":"10.1016\/j.neuro.2015.05.004_bib0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/WNL.41.2_Part_1.272","article-title":"Comparison of functional and structural brain disturbances in Wilson's disease","volume":"41","author":"Grimm","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neuro.2015.05.004_bib0080","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","article-title":"Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury","volume":"9","author":"Janero","year":"1990","journal-title":"Free Radic Biol Med"},{"issue":"3\u20134","key":"10.1016\/j.neuro.2015.05.004_bib0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000355276","article-title":"Worsening of Wilson disease following penicillamine therapy","volume":"71","author":"Kalita","year":"2014","journal-title":"Eur Neurol"},{"issue":"1\u20132","key":"10.1016\/j.neuro.2015.05.004_bib0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2014.06.013","article-title":"A study of oxidative stress, cytokines and glutamate in Wilson disease and their asymptomatic siblings","volume":"274","author":"Kalita","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.neuro.2015.05.004_bib0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00415-004-0555-4","article-title":"Serial diffusion-weighted MRI in a case of Wilson's disease with acute onset hemichorea","volume":"251","author":"Kawamura","year":"2004","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.neuro.2015.05.004_bib0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12011-008-8219-3","article-title":"Copper intoxication; antioxidant defenses and oxidative damage in rat brain","volume":"127","author":"Ozcelik","year":"2009","journal-title":"Biol Trace Elem Res"},{"issue":"6","key":"10.1016\/j.neuro.2015.05.004_bib0055","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.neuro.2015.05.004_bib0030","first-page":"212","article-title":"Copper imbalance and oxidative stress in neurodegeneration","volume":"55","author":"Rossi","year":"2006","journal-title":"Ital J Biochem"},{"issue":"3","key":"10.1016\/j.neuro.2015.05.004_bib0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbadis.2005.06.004","article-title":"Oxidative stress and pro-apoptotic conditions in a rodent model of Wilson's disease","volume":"1741","author":"Samuele","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neuro.2015.05.004_bib0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1148\/radiology.217.2.r00nv24331","article-title":"Diffusion-weighted MR imaging of the brain","volume":"217","author":"Schaefer","year":"2000","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.neuro.2015.05.004_bib0090","first-page":"965","article-title":"Diffusion MR imaging changes associated with Wilson disease","volume":"24","author":"Sener","year":"2003","journal-title":"Am J Neuroradiol"},{"issue":"957","key":"10.1016\/j.neuro.2015.05.004_bib0085","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1259\/bjr\/48911350","article-title":"Sequential MRI changes in Wilson's disease with de-coppering therapy: a study of 50 patients","volume":"80","author":"Sinha","year":"2007","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.neuro.2015.05.004_bib0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ng1293-344","article-title":"The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene","volume":"5","author":"Tanzi","year":"1993","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.neuro.2015.05.004_bib0010","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng0295-210","article-title":"The Wilson disease gene: spectrum of mutations and their consequences","volume":"9","author":"Thomas","year":"1995","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.neuro.2015.05.004_bib0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0003-2697(69)90064-5","article-title":"Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues","volume":"27","author":"Tietze","year":"1969","journal-title":"Anal Biochem"}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X15000790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X15000790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T08:24:10Z","timestamp":1537604650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X15000790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":26,"alternative-id":["S0161813X15000790"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2015.05.004","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI and oxidative stress markers in neurological worsening of Wilson disease following penicillamine","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}